BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help
Documents 1-9 out of 9 found
  Current Search:  camila: 13, norethindrone: 304  
100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE #3, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN W/ CODEINE, ACETAMINOPHEN ACETAMINOPHEN, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN AND CAFFEINE, ACETAMINOPHEN (OTC) ACETAMINOPHEN, ASPIRIN, AND CODEINE PHOSPHATE, ACETAMINOPHEN ACETAMINOPHEN, BUTALBITAL AND CAFFEINE, ACETAMINOPHEN ACETAMINOPHEN,...

Matching: camila norethindrone Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 10/2002
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE TABLET; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN -A- AA ABLE 325MG;7.5MG N40464 001 OCT 23, 2002 OCT NEWA -A- AA 325MG;10MG N40464 002 OCT 23, 2002 OCT NEWA -A- AA 650MG;10MG N40476 001 OCT 23, 2002 OCT NEWA -A- AA 750MG;7.5MG N40469 001 OCT 25, 2002 OCT NEWA -A- AA MALLINCKRODT 750MG...
Matching: camila norethindrone Find similar documents More document info
57%
HTML
Barr Pharmaceuticals, Inc.
Contact Us Product Guide Drug Information Site Map Legal Notices Barr's web sites (the -Sites-) contain many valuable trademarks owned and/or used by Barr Pharmaceuticals, Inc.
The content, arrangement and layout of the Sites, including, but not limited to, the trademarks and text, are proprietary to Barr, and should not be copied, used, imitated, reproduced, displayed,...
Matching: camila Find similar documents More document info
57%
PDF
Pages
Barr Laboratories, Inc.
's Provigil® (Modafinil), for patients experiencing excessive daytime sleepiness associated with narcolepsy.
Expanding Our Proprietary Sales & Marketing Team As critical as new product development is, the need for an agile and efficient sales and marketing capability will be critical to realizing the value of our proprietary development activities....

author: Lisa
Matching: camila Find similar documents More document info

57%
PDF
Pages page 59


author: Lisa
Matching: camila Find similar documents More document info

57%
PDF
Pages page 14


author: Lisa
Matching: camila Find similar documents More document info

57%
HTML
Cell -- Table of Contents (Nov 27, 2002, 111 (5))
Register for free access to issue alerts, summaries, and pay per article. Browse Archive: - November 27, 2002: 111 (5) "Syndecan Shedding by Matrilysin in Lung Injury" [Cover Caption] - Minireviews- Pages - ...
Matching: camila Find similar documents More document info
57%
HTML
"Genetically Modified Organisms: Implications for Mexico and Chiapas"
"Genetically Modified Organisms: Implications for Mexico and Chiapas" English version of "Chiapas Al Dia" No 165 Ciepac Chiapas, Mexico August 8, 1999 Genetically Modified Organisms (GMOs, also known as ...
Matching: camila Find similar documents More document info
57%
HTML
New Patent Aims to Prevent Farmers from Saving Seed
"New Patent Aims to Prevent Farmers from Saving Seed " RAFI Press Release March 13, 1998 By the year 2000 - after a 12,000-year history of farming - farmers may no longer be able to save seed or breed ...
Matching: camila Find similar documents More document info
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.